Perillyl alcohol and genistein differentially regulate PKB/Akt and 4E-BP1 phosphorylation as well as eIF4E/eIF4G

Dennis M Peffley1, Catherine Sharma, Patricia Hentosh

  • 1Department of Biochemistry, Kansas City University of Medicine and Biosciences, 1750 Independence Avenue, Kansas City, MO 64106-1453, USA. dpeffley@odu.edu

Insights

Plant-derived isoprenoids and genistein differentially affect cancer cell translation pathways. Perillyl alcohol and genistein inhibit key signaling proteins, impacting tumor cell growth and survival.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Isoprenoids, secondary metabolites of plant mevalonate metabolism, are known to inhibit 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA translation and induce tumor cell death.
  • The PKB/Akt/mTOR pathway is a critical regulator of mRNA translation and cell growth, making it a target for cancer therapies.

Purpose of the Study:

  • To compare the effects of pure isoprenoids (perillyl alcohol, gamma-tocotrienol) and a mixed isoprenoid-genistein treatment on the PKB/Akt/mTOR pathway.
  • To investigate the impact of these compounds on mRNA translation initiation complex formation (eIF4F).

Main Methods:

  • Cell-based assays using prostate cancer cell lines (DU145, PC-3) and adenocarcinoma cells (Caco2).
  • Western blotting to assess phosphorylation levels of key proteins in the PKB/Akt/mTOR pathway (e.g., 4E-BP1, Akt).
  • Analysis of protein-protein interactions within the eIF4F cap-binding complex.

Main Results:

  • Perillyl alcohol and genistein suppressed 4E-BP1(Ser65) phosphorylation in DU145, PC-3, and Caco2 cells, comparable to PI3K or mTOR inhibitors.
  • Differential effects on 4E-BP1(Thr37) phosphorylation were observed across cell lines and compounds.
  • PKB/Akt activation was enhanced by perillyl alcohol (DU145) and gamma-tocotrienol (PC-3), but suppressed by genistein.
  • Perillyl alcohol disrupted the interaction between eIF4E and eIF4G, crucial for cap-dependent translation.

Conclusions:

  • Pure isoprenoids and genistein exhibit cell- and compound-specific effects on the PKB/Akt/mTOR pathway.
  • These compounds differentially modulate cap-dependent translation initiation in tumor cells.
  • Findings highlight the potential of specific isoprenoids and genistein as targeted agents impacting cancer cell translation.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...